Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide LP 90 mg vs placebo to reduce postoperative lymphorrhea after axillary lymph node dissection in breast cancer
2007-003576-19Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Aug 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Lanreotide LP 90 mg with Placebo (2 arms). Started Aug 2007; status: completed.
02
Drugs
lanreotide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-003576-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003576-19.